Conceivable Life Sciences
What They Do
Conceivable Life Sciences operates semi-autonomous fertility labs that encompass a bundle of cutting-edge technologies applied to in-vitro fertilization (IVF), from advanced single cell robotics to AI-driven sperm selection to sample storage.
This end-to-end automation of the entire embryology process aims to eliminate human error in the lab, reduce costs by 70% for patients, and enable a new expanded generation of families to successfully navigate the journey to parenthood.
Why We Invested
In the past half-century, IVF has evolved from a scientific breakthrough to a popular option for affluent patients. Unfortunately, limited innovation has left IVF a manual, highly variable process, resulting in high costs, limited access for most families, and variable outcomes.
We believe Conceivable can address these deficiencies, opening up access to a much wider range of patients while enhancing the quality and consistency of outcomes. The company’s team includes IVF pioneers Jacques Cohen and Alejandro Chavez-Badiola, complemented by executive leadership with a track record of successful start-ups across industries.